NEW YORK (Reuters Health) – With the introduction of more intensive medical therapy, revascularization for asymptomatic carotid stenosis is likely to benefit less than 5% of patients, according…
NEW YORK (Reuters Health) – While raloxifene and tamoxifen are broadly similar in reducing breast cancer risk, raloxifene appears also to lower the odds of developing endometrial cancer,…
NEW YORK (Reuters Health) – Alteplase can improve stroke outcomes even when it is not given until 3 to 4.5 hours after the stroke began, according to a…
NEW YORK (Reuters Health) – Randomized trials have shown a survival benefit to using drug-eluting stents (DES) rather than bare-metal stents (BMS) in heart disease patients. Now, the…
NEW YORK (Reuters Health) – In the treatment of lower urinary tract symptoms in men, extended-release oxybutynin plus tamsulosin is more effective than tamsulosin alone and just as…
NEW YORK (Reuters Health) – Adults with subclinical hypothyroidism are at increased risk for heart failure and for changes in cardiac function, new research suggests. Subclinical hyperthyroidism, by…
NEW YORK (Reuters Health) – The risk of lung cancer is increased in patients with rheumatoid arthritis, even after taking into account the effects of tobacco and asbestos…
NEW YORK (Reuters Health) – The results of a randomized trial suggest that statins may be a useful treatment for Raynaud’s phenomenon and digital ulcers that can accompany…
NEW YORK (Reuters Health) – The results of a new study indicate that the intradermal vaccination route offers greater protection against influenza than the standard intramuscular route in…
NEW YORK (Reuters Health) – Patients who quit smoking after undergoing coronary artery bypass graft (CABG) surgery can expect to live 3 years longer than patients who continue…
